Literature DB >> 17437436

Immunohistochemical markers in urinary bladder carcinomas from paraffin-embedded archival tissue after storage for 5-70 years.

Jorunn Litlekalsoy1, Vendil Vatne, Jens G Hostmark, Ole Didrik Laerum.   

Abstract

OBJECTIVE: To evaluate archival tissue specimens from bladder tumours and seek molecular changes in samples collected over seven decades previously, as although the frequencies of some cancer types have remained stable during the last 50 years, the incidence of others, including bladder tumours, has increased significantly, and molecular analyses of bladder cancer over periods with an increasing incidence are of interest as the findings might reflect varying external influences.
MATERIALS AND METHODS: Immunohistochemical staining with the biological markers p53 protein, p16 protein, epidermal growth factor receptor (EGFR), cytokeratin 7 and high molecular weight 34betaE12 cytokeratin (HMW-cytokeratin, characteristic of basal cells) was used on archival, paraffin wax-embedded autopsy/biopsy tissue material collected from 144 patients with invasive bladder cancer (World Health Organisation grade II and III). The cases were selected from the periods 1932-48, 1950-59, 1960-70 and 1990-2004. Control immunohistochemistry was done on available normal tissue (i.e. connective and fatty tissue, heart, lungs and normal urinary bladder epithelium) obtained from the autopsies.
RESULTS: The normal tissues were all largely negative for EGFR, had <1% positively stained nuclei for p53 and strong positive reactions for p16, and in epithelial tissues the two cytokeratins were detected. The positive scores for HMW-cytokeratin in the tumour tissue decreased significantly from approximately 90% to 30% over the 70 years. For p53 there was a higher fraction of positive scores (borderline significant) with time. The p16-positive tumours showed no significant variation, with the highest frequency of positive scores in recent years. Overexpression of EGFR in the tumours was significantly correlated with the occurrence of HMW-cytokeratin and decreased from approximately 85% to 65% (not significant), with the lowest frequency in the samples from 1990 to 2004. Autolysis after death or long storage periods did not compromise good quality in the histochemical analyses of the autopsy tissue.
CONCLUSION: The higher frequency of HMW-cytokeratin, lower p53 accumulation and more EGFR expression in grade II and III urinary bladder carcinomas from the 1930s could indicate different phenotypes in bladder cancer during this 70-year period. The successful detection of these protein markers in old archival material allows larger retrospective studies that might increase the understanding of molecular carcinogenesis in bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437436     DOI: 10.1111/j.1464-410X.2006.06699.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

1.  Effects of long-term storage on the detection of proteins, DNA, and mRNA in tissue microarray slides.

Authors:  Christina Karlsson; Mats G Karlsson
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

2.  Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections.

Authors:  Federica Grillo; Simona Pigozzi; Paola Ceriolo; Paola Calamaro; Roberto Fiocca; Luca Mastracci
Journal:  Histochem Cell Biol       Date:  2015-03-11       Impact factor: 4.304

3.  Time-dependent biological differences in molecular markers of high-grade urothelial cancer over 7 decades (ras proteins, pTEN, uPAR, PAI-1 and MMP-9).

Authors:  Jorunn Litlekalsoy; Jens G Hostmark; Daniela Elena Costea; Martin Illemann; Ole Didrik Laerum
Journal:  Virchows Arch       Date:  2012-10-06       Impact factor: 4.064

4.  Quantitative RNA assessment and long-term stability in the FFPE tumor samples using Digital Spatial Profiler.

Authors:  S Gupta; T Chen; B Destenaves
Journal:  Immunooncol Technol       Date:  2021-12-28

5.  Can Archival Tissue Reveal Answers to Modern Research Questions?: Computer-Aided Histological Assessment of Neuroblastoma Tumours Collected over 60 Years.

Authors:  Albert Chetcuti; Nicole Mackie; Siamak Tafavogh; Nicole Graf; Tony Henwood; Amanda Charlton; Daniel Catchpoole
Journal:  Microarrays (Basel)       Date:  2014-02-28

6.  Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression.

Authors:  Andrey A Rosenkranz; Tatiana A Slastnikova; Tatiana A Karmakova; Maria S Vorontsova; Natalia B Morozova; Vasiliy M Petriev; Alexey S Abrosimov; Yuri V Khramtsov; Tatiana N Lupanova; Alexey V Ulasov; Raisa I Yakubovskaya; Georgii P Georgiev; Alexander S Sobolev
Journal:  Front Pharmacol       Date:  2018-11-19       Impact factor: 5.810

Review 7.  Biobanking in health care: evolution and future directions.

Authors:  Luigi Coppola; Alessandra Cianflone; Anna Maria Grimaldi; Mariarosaria Incoronato; Paolo Bevilacqua; Francesco Messina; Simona Baselice; Andrea Soricelli; Peppino Mirabelli; Marco Salvatore
Journal:  J Transl Med       Date:  2019-05-22       Impact factor: 5.531

8.  Study on PD-L1 Expression in NSCLC Patients and Related Influencing Factors in the Real World.

Authors:  Yefei Zhu; Shuangxiang Lin; Yueping Wang; Bingxiao Shen; Ling Lin; Liangxing Wang; Susu He
Journal:  Comput Math Methods Med       Date:  2021-12-28       Impact factor: 2.238

9.  Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes.

Authors:  Jorunn Litlekalsoy; Kari Rostad; Karl-Henning Kalland; Jens G Hostmark; Ole Didrik Laerum
Journal:  BMC Cancer       Date:  2016-07-27       Impact factor: 4.430

10.  Methods for restoration of ki67 antigenicity in aged paraffin tissue blocks.

Authors:  Federica Grillo; Michela Campora; Simona Pigozzi; Silvia Bonadio; Luca Valle; Jacopo Ferro; Michele Paudice; Beatrice Dose; Luca Mastracci
Journal:  Histochem Cell Biol       Date:  2021-04-10       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.